SCHULMAN AMY W

SEC Form 4 insider trading activity

SCHULMAN AMY W has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including ALNY, ELV, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: May 22, 2026.

On the most recent filing, SCHULMAN AMY W is listed as Director at Elevance Health, Inc. Inside the rolling window, SCHULMAN AMY W reported no open-market purchases and 1 open-market sale totaling $7K in ELV.

Companies traded

Other insiders at ALNY

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$7K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
ELV
SCHULMAN AMY W
Sale$7KMar 23SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has SCHULMAN AMY W made?

SCHULMAN AMY W has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including ALNY, ELV since 2026.

Which companies does SCHULMAN AMY W trade?

SCHULMAN AMY W has filed SEC Form 4 disclosures for 2 companies, including ALNY, ELV.

When was SCHULMAN AMY W's most recent SEC Form 4 filing?

SCHULMAN AMY W's most recent SEC Form 4 filing on Tracefour is dated May 22, 2026.

What is SCHULMAN AMY W's total buy and sell value in the current window?

Inside the rolling retention window, SCHULMAN AMY W bought $0 and sold $7K based on SEC Form 4 filings.

What was SCHULMAN AMY W's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 26 ELV shares on 2026-03-12, worth $7K, per SEC Form 4 filings.